Showing 2,421 - 2,440 results of 3,158 for search 'Patient Number 9', query time: 0.09s Refine Results
  1. 2421

    Possible association between Sever’s disease and attention deficit hyperactivity disorder. a prospective observational study by Nevzat Gonder, Ibrahim Halil Demir, Volkan Özel, Kubra Ilicepinar, Musa Alperen Bilgin

    Published 2025-01-01
    “…ADHD was detected in 12 (13.3%) of 90 patients in the control group, comprising 9 boys and 3 girls. …”
    Get full text
    Article
  2. 2422
  3. 2423

    Development of a clinical decision support tool for Primary care Management of lower Urinary tract Symptoms in men: the PriMUS study by Adrian Edwards, Ridhi Agarwal, Janine Bates, Alison Bray, Sarah Milosevic, Emma Thomas-Jones, Michael Drinnan, Marcus Drake, Peter Michell, Bethan Pell, Haroon Ahmed, Natalie Joseph-Williams, Kerenza Hood, Yemisi Takwoingi, Chris Harding

    Published 2025-01-01
    “…It will also be important to capture important patient-based outcomes, potentially including patients’ confidence in treatment decisions, adherence to treatment decisions (also affecting resource use measures) and patient safety. …”
    Get full text
    Article
  4. 2424
  5. 2425
  6. 2426

    Anti-inflammatory treatment using alpha melanocyte stimulating hormone (α-MSH) does not alter osteoblasts differentiation and fracture healing by Johanna Graue, Melanie Timmen, Katharina Schmitz, Daniel Kronenberg, Markus Böhm, Kishor K. Sivaraj, M. Gabriele Bixel, Richard Stange

    Published 2025-02-01
    “…We can conclude from our results, that treatment of inflammatory diseases using α-MSH does not interfere significantly with bone regeneration in a murine fracture model and therefore treatment with α-MSH could be continued without negative effects on bone formation and bone regeneration in patients. Clinical trial number Not applicable.…”
    Get full text
    Article
  7. 2427
  8. 2428
  9. 2429
  10. 2430
  11. 2431

    Durvalumab and tremelimumab in combination with metronomic oral vinorelbine for recurrent advanced cervical cancer: an open-label phase I/II study by Pernelle Lavaud, Esma Saada-Bouzid, Renaud Sabatier, Olivia Le Saux, Thibault de la Motte Rouge, Anthony Gonçalves, Elodie Coquan, Jean-Sébastien Frenel, Marta Jiménez, Alice Hervieu, Laurent Mathiot, François Legrand, Claire Cropet, Edith Borcoman, Emmanuelle Charafe

    Published 2025-01-01
    “…Of the 31 patients, 28 (90.3%) experienced treatment-related adverse events (TRAEs), 13 (41.9%) reported grade ≥3 immune-related adverse events (AEs), and 13 (41.9%) reported grade ≥3 chemotherapy-related AEs. …”
    Get full text
    Article
  12. 2432
  13. 2433
  14. 2434
  15. 2435
  16. 2436
  17. 2437

    The Effect of Various Combinations of Peripheral Nerve Blocks on Postoperative Pain in Laparoscopic Cholecystectomy: A Comparative Prospective Study by Zoya Haitov Ben Zikri, Maryna Volis, Andrei Mazur, Tatjana Orlova, Hana Alon, Sara Bar Yehuda, Vladislav Gofman

    Published 2023-01-01
    “…The mean/median number of medications consumed by each of the patients was lower among the patients who received a combination of 2 blocks compared to those who received a single one (mean/median of 2.7/3 and 2.8/3 for the TAP or subcostal TAP blocks, respectively; 2.5/2 and 2.3/2 for the subcostal TAP + TAP or subcostal TAP + rectus sheath blocks, respectively). …”
    Get full text
    Article
  18. 2438
  19. 2439
  20. 2440

    Neutropenic Sepsis in the ICU: Outcome Predictors in a Two-Phase Model and Microbiology Findings by Jan M. Kruse, Thomas Jenning, Sibylle Rademacher, Renate Arnold, Clemens A. Schmitt, Achim Jörres, Philipp Enghard, Michael Oppert

    Published 2016-01-01
    “…The overall ICU mortality was 54.9%. The severity of sepsis and the number of organ failures predicted survival of the primary septic episode (APACHE II 22.8 and 29.0; SOFA 7.3 and 10.1, resp.). …”
    Get full text
    Article